Exchange: OTC·Updated 03:30 PM EDT

DSNKY Daiichi Sankyo Company

$18.81
$0.026
(0.14%)
Today
EarningsOct 30
Mkt Cap$34.3B
Vol41,365.00

About DSNKY

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded in 2005 and is headquartered in Tokyo, Japan.
51

Neutral Sentiment

How do you feel about DSNKY?

Advertisement|Remove ads.